Tetratherix (ASX:TTX) EBITDA Margin %: 0.00% (As of Dec. 2025)


ASX:TTX Tetratherix Ltd ASX:TTX
15 GF Score
Price A$6.12
View Full Analysis

What is Tetratherix EBITDA Margin %?

Tetratherix ASX:TTX -1.45% 15 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates ASX:TTX with a GF Score™ of 15/100. Among 944 Biotechnology companies, Tetratherix ranks worse than 105932.1% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Tetratherix's EBITDA for the six months ended in Dec. 2025 was A$-4.19 Mil. Tetratherix's Revenue for the six months ended in Dec. 2025 was A$0.00 Mil. Therefore, Tetratherix's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.

Tetratherix  (ASX:TTX) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Tetratherix EBITDA Margin % Related Terms

Tetratherix EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Tetratherix's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tetratherix EBITDA Margin % Chart

Tetratherix Annual Data
Trend Jun23 Jun24 Jun25
EBITDA Margin %
0.00 0.00 0.00

Tetratherix Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

ASX:TTX vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Tetratherix's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tetratherix EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tetratherix's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Tetratherix's EBITDA Margin % falls into.


ASX:TTX
15GF Score
Tetratherix Ltd ASX:TTX
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tetratherix EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Tetratherix's EBITDA Margin % for the fiscal year that ended in Jun. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-9.277/0
= %

Tetratherix's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-4.191/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Tetratherix (ASX:TTX) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Tetratherix and its competitors. According to the industry distribution chart, Tetratherix ranks #999999 out of 944 companies in the Biotechnology industry.
Is Tetratherix's EBITDA Margin % too high?
Tetratherix's current EBITDA Margin % is 0.00%. Based on the distribution chart, Tetratherix ranks #999999 out of 944 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Tetratherix has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Tetratherix's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Tetratherix ranks #999999 out of 944 companies for EBITDA Margin %. This places Tetratherix in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Tetratherix and its competitors. Tetratherix's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tetratherix stock overvalued right now?
Tetratherix (ASX:TTX) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Tetratherix's overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Tetratherix (ASX:TTX), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tetratherix Business Description

Address 34-36 Ralph Street, Unit 29, Alexandria, Sydney, NSW, AUS, 2015
Tetratherix Ltd is a biomedical company that has developed an biomaterial platform called Tetramatrix, a proprietary fluid matrix that induces minimal foreign body reaction. The principal activities include development programs in the areas of regenerative medicine and commercialising medical device technology across multiple applications including Bone Regeneration, Tissue Spacing and Tissue Healing.
15GF Score

Get the complete analysis for ASX:TTX

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$6.12
Price